← brief for 2026-09-25 · Transplant & xeno

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

Key takeaways

This is a study that is starting. It will watch people who get a kidney transplant after taking a drug called vonsetamig. No new drug will be given. There are no results yet.

Who did this work

Run by Regeneron Pharmaceuticals. Clinical Trial Management (Regeneron Pharmaceuticals)
Sites: Cedars-Sinai Medical Center · University of California Irvine · Connie Frank Transplant Center at UCSF · Yale University of Medicine · Comprehensive Transplant Center · John Hopkins Hospital

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-09-25
https://clinicaltrials.gov/study/NCT05106387